Skip to main content
Erschienen in: BMC Pulmonary Medicine 1/2021

Open Access 01.12.2021 | Case report

Crazy‐paving patterns as rare radiological manifestations of pulmonary cryptococcosis: a case report

verfasst von: He Yu, Kaige Wang, Dong Huang, Lu Wen, Ying Zhang, Ye Wang, Yongjiang Tang, Jiajia Dong, Zongan Liang

Erschienen in: BMC Pulmonary Medicine | Ausgabe 1/2021

Abstract

Background

Crazy-paving patterns are rarely reported as radiological manifestations of pulmonary cryptococcosis.

Case presentation

Herein, we presented a very rare case of a crazy-paving pattern as a radiological manifestation of pulmonary cryptococcosis in a patient with primary ciliary dyskinesia. The diagnosis of pulmonary cryptococcosis and primary ciliary dyskinesia was ultimately confirmed by bronchoscopic biopsy, fungus culture, whole exome sequencing of blood, etc. The patient received flucytosine (PO, 5 g per day) and amphotericin B (IV, 70 mg per day) during hospitalization and sequential therapy with voriconazole (PO, 200 mg twice a day) after discharge. He recovered during follow-up.

Conclusions

We concluded that pulmonary cryptococcosis should be considered a possible cause of crazy-paving patterns in chest CT scans.
Hinweise
He Yu, Kaige Wang and Dong Huang contributed equally to this work

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
HRCT
High resolution computed tomography
RR
Respiratory rate
PAS
Periodic Acid-Schiff
CSF
Cerebrospinal fluid
MRI
Magnetic resonance imaging
HFNC
High-flow nasal cannula
ARDS
Acute respiratory distress syndrome

Background

Pulmonary cryptococcosis is a common opportunistic infectious disease [1]. The crazy-paving pattern refers to areas of ground-glass attenuation associated with inter- and intralobular septal thickening on chest high-resolution CT (HRCT) [2]. However, it has rarely been reported as a radiological manifestation of pulmonary cryptococcosis. We herein presented a very rare case of a crazy-paving pattern as a radiological manifestation of pulmonary cryptococcosis in a patient with primary ciliary dyskinesia.

Case presentation

The patient was a 46-year-old male construction worker. He presented to our hospital with complaints of cough with a small amount of white sputum without obvious cause for three months and with fever and dyspnea for six days. There were no complaints of chills or chest pains. He had been administered cefoperazone-sulbactam at another institution a few days prior to admission at our hospital. However, the therapeutic effect was unsatisfactory. He had been diagnosed with secondary bilateral pulmonary tuberculosis at our institute four years ago. After receiving regular anti-tuberculosis treatments with “2HREZ/10HRE”, his symptoms of cough and shortness of breath improved. Since then, the patient failed to participate in follow-up. There was no history of possible poultry exposure, smoking or drinking. On admission, he was conscious. The physical examination revealed a respiratory rate of 28 breaths/min. Lung percussion of the right lower lobe showed dullness and flatness. On lung auscultation, weak breath sounds were heard in the right lower lobe, and diffuse bilateral moist rales were also heard. A complete laboratory examination was performed, and the significant laboratory findings were as follows. The white blood cell level was 13.05 × 109/L, and the percentage of neutrophils was 88.3%. The level of procalcitonin was 0.21 g/ml, and the PaO2/FiO2 ratio was 115 mmHg during noninvasive mechanical ventilation. The carcinoembryonic antigen level was 14.7 ng/ml, and the CD4 T cell count was 48 cells/µl. The test for human immunodeficiency virus infection was negative. Anti-nuclear antibodies, anti-extracted nuclear antigen (ENA) autoantibodies, myositis-specific antibodies, and anti-neutrophil cytoplasmic antibodies (ANCAs) were all negative. Chest HRCT (Fig. 1a–c) revealed a bilateral, diffuse reticular pattern accompanied by ground-glass opacity, which was called a “crazy-paving pattern”. Furthermore, patchy consolidation was found in the right lower lobe. There was no pulmonary nodule, pleural effusion or mediastinal lymphadenopathy. After admission, the patient was given moxifloxacin (400 mg, IV, once a day), methylprednisolone (40 mg, IV, twice a day) and a noninvasive ventilator.
After 5 days of antibiotic treatment, his symptoms did not improve. As a result, further examinations were performed. The test of serum cryptococcal antigen was positive, and the titer of cryptococcal antigen was greater than 1:2560. The patient underwent bronchoscopy, and bronchoalveolar lavage fluid (BALF) from the right upper lobe was obtained. The BALF was clear and bright in appearance. Periodic acid-Schiff (PAS) staining showed a small number of suspected positive protein-like bodies. The alcian blue staining result was negative. Next-generation sequencing (NGS) of the bronchoalveolar lavage fluid showed Cryptococcus neoformans with 3605 reads. Consistently, fungal culture of the BALF showed the growth of Cryptococcus neoformans, which was sensitive to fluconazole. Nucleic acid testing of Pneumocystis jiroveci from the BALF showed negative results. To further confirm the diagnosis, a CT-guided percutaneous lung biopsy was performed. Pathologic examination showed the proliferation of alveolar epithelial cells and diffuse infiltration of foam cells, inside of which a large number of spherical fungi were found (Fig. 2a–c). The staining results were as follows: silver staining (+), PAS (+), Mayer’s dyeing (+), d-PAS (+), and acid fast staining (−). According to these results, the diagnosis of pulmonary Cryptococcus neoformans infection was established. Furthermore, a lumbar puncture was performed to check whether the central nervous system was involved. The cerebrospinal fluid (CSF) was essentially normal. The pressure of the CSF was 145 mm H2O. The CSF was colorless and transparent in appearance, and no nucleated cells, red blood cells or pus cells were found. Biochemical tests of the CSF included trace protein: 0.43 g/L, chlorine: 119 mmol/L, and glucose: 4.58 mmol/L. The ink stain of the CSF was negative. Magnetic resonance imaging (MRI) of the head presented normal results. Based on the above results, the anti-infective treatments were changed to fluconazole (600 mg, IV, once a day) and piperacillin-tazobactam (4.5 g, IV, every 8 h).
However, after 20 days of antifungal therapy, the patient still suffered from respiratory distress. Additionally, the PaO2/FiO2 ratio did not increase significantly. A repeated chest CT scan was performed (Fig. 1d, e), which indicated that the patchy consolidation had decreased but the bilateral reticular pattern had increased significantly. The patient underwent new bronchoscopy after informed consent was obtained. Lung biopsy of the right upper lobe revealed proliferation of alveolar epithelial cells and interstitial fibroblasts, diffuse inflammatory infiltration, and a broken bronchial mucosal epithelium. The second fungal culture of the BALF showed Cryptococcus neoformans, which was resistant to fluconazole but sensitive to 5-fluorocytosine and amphotericin B. The titer of the Cryptococcus antigen was still greater than 1:2560. To identify underlying comorbidities and possible risk factors for pulmonary cryptococcosis, further bronchoscopic biopsy of the bronchial mucosa was also completed. Electron microscopic examination showed bronchociliary outer dynein arm partial defects (Fig. 2d). There were some significant findings of whole exome sequencing of the blood: heterozygous mutations in the DNAH5 gene (EX66, change in DNA: NM_001369.2: c.11350G>A, change in amino acids: P. Va13784Met; EX21, and change in DNA: NM_001369.2: c.3234T>C, change in amino acids: p. Asp1078Asp). The patient did not have any other features or positive findings of primary ciliary dyskinesia. His mother died of hypertension and stroke, and his father was still living and in good health. His sons were both healthy without any known pulmonary diseases.
Finally, the patient was diagnosed with the following: (1) severe pulmonary cryptococcosis; (2) type I respiratory failure; and (3) primary ciliary dyskinesia. Patient treatments mainly included infection control and respiratory support. The antifungal therapies were also adjusted to flucytosine (PO, 5 g per day) and amphotericin B (IV, 70 mg per day) according to the results of drug sensitivity analysis. Two weeks later, the treatment was changed to voriconazole (PO, 200 mg, twice a day). Additionally, the noninvasive ventilator was gradually changed to a high-flow nasal cannula (HFNC). Finally, the patient was discharged after significant improvements in oxygenation.
Two months after discharge, the patient underwent follow-up. The chest HRCT scan showed significant improvement (Fig. 1f–h): the patchy consolidation in the right lower lobe and crazy-paving pattern in the bilateral upper lobes decreased significantly. Moreover, the CD4 T cell counts also returned to normal (540 cell/µl). The flow of diagnosis and treatments of the patient is shown in Table 1.
Table 1
Flow of diagnosis and treatments
Indexes
Normal range
Hospitalization
Discharged from hospital
Day 1
Day 5
Day 10
Day 20
Day 35
Day 40 (discharge)
40 days after discharge
White blood cell count (×109/L)
3.5–9.5
13.05
10.07
17.77
23.85
7.42
6.94
5.36
Neutrophil (%)
40–75
88.3
92.4
83.2
96.9
82.2
76.3
57.3
CD4 T cell count (cell/µL)
471–1220
48
115
316
434
PCT (ng/mL)
0–0.05
0.21
0.07
0.1
0.61
0.11
0.05
PaO2/FiO2 ratio (mmHg)
400–500
115
110
105
110
160
240
360
Etiological examination
  
NGS (BALF): Cryptococcus neoformans; serum cryptococcal antigen: positive; lung biopsy: cryptococcus
fungus culture of BALF: Cryptococcus neoformans, resistant to fluconazole
  
Image
 
Figure 1a–c
 
Figure 1d, e
 
Figure 1f–h
Drugs
 
Moxifloxacin: 400 mg qd; methylprednisolone: 40 mg bid
Fluconazole: 600 mg qd; piperacillin-tazobactam: 4.5 g q 8 h
Flucytosine: 5 g qd PO; amphotericin B: 70 mg qd
Voriconazole: 200 mg bid PO
Voriconazole: 200 mg bid PO
Respiratory support
 
Noninvasive ventilator
HFNC
nasal cannula
 
NGS next-generation sequencing, BALF bronchoalveolar lavage fluids, HFNC high-flow nasal cannula

Discussion and conclusions

We reported the first case of a crazy-paving pattern as a radiological manifestation of pulmonary cryptococcosis. Detailed etiological examination ruled out infections from viruses, pneumocystis or other pathogens. The bronchoscopy results were inconsistent with pulmonary alveolar proteinosis. Considering previous infection with Mycobacterium tuberculosis and current severe Cryptococcus neoformans pneumonia, we suspected that the patient might be immunocompromised. This speculation was finally verified by electron microscopic examination and whole exome sequencing of the blood.
A crazy-paving pattern was first used to describe the imaging characteristics of pulmonary alveolar proteinosis. Currently, this manifestation can be identified in pulmonary edema, nonspecific interstitial pneumonia, pulmonary hemorrhage, sarcoidosis, viral infection, peripheral T-cell lymphoma, invasive mucinous adenocarcinoma, etc. [26]. Cryptococcosis has become a common opportunistic infectious disease due to several factors, such as climate change, the evolution of Cryptococcus, and the growth of the pathogen in a number of susceptible populations [7]. The most common transmission of Cryptococcus causing infection is via inhalation. Spores of Cryptococcus may reach the lower airways and pulmonary alveoli. Respiratory defenses such as mucociliary transport do not prevent these spores from reaching the distal alveoli. [8] The central nervous system and lung are the most commonly involved and infected organs. In most cases, the symptoms of pulmonary cryptococcosis are nonspecific, including cough, expectoration, chest tightness, fatigue, etc. The patients’ conditions might vary from asymptomatic to severe acute respiratory distress syndrome (ARDS) [9]. It should be noted that the severity and radiological features of pulmonary cryptococcosis largely depend on the immune status of the patient. Symptoms of immunocompetent patients are often mild or even absent. However, immunocompromised patients often have extensive and severe symptoms or even disseminated cryptococcosis. Patients might develop fever, shortness of breath, hypoxemia and acute respiratory failure in a short time [10]. For chest CT scans, localized solitary or multiple peripheral nodules or pneumonia-like lesions are the most common imaging characteristics in immunocompetent patients. Diffuse pneumonia-like infiltration and consolidation with cavities and “halo signs” are more likely to be found in immunocompromised patients [11].
Primary ciliary dyskinesia is a rare ciliopathic genetic disorder that causes defects in cilia action. DNAH5 is a main ciliary dyskinesia gene, and mutations of DNAH5 have been identified in 15 % of primary ciliary dyskinesia patients [12]. The heterozygous mutations in the DNAH5 gene that occurred in EX66 and EX21 in our patient have rarely been reported previously. Abnormal expression of mutated DNAH5 proteins leads to outer dynein arm defects and decreased cilia movement. As a result, patients experience recurrent airway infections or systemic opportunistic infections [13]. Therefore, pulmonary cryptococcosis should be considered a possible cause of crazy-paving patterns in chest CT scans. It is necessary and crucial to carefully identify possible underlying diseases causing immunodeficiency for patients with severe cryptococcal infections.
interest to disclosure.

Acknowledgements

None.

Declarations

Appropriate written informed consent was obtained for the publication of this case report and accompanying images. It was approved by the Clinical Research Ethics Committee of West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Competing interests

The authors declare that they they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Setianingrum F, Rautemaa-Richardson R, Denning DW. Pulmonary cryptococcosis: a review of pathobiology and clinical aspects. Med Mycol. 2019;57(2):133–50.CrossRef Setianingrum F, Rautemaa-Richardson R, Denning DW. Pulmonary cryptococcosis: a review of pathobiology and clinical aspects. Med Mycol. 2019;57(2):133–50.CrossRef
2.
Zurück zum Zitat Rossi SE, Erasmus JJ, Volpacchio M, Franquet T, Castiglioni T, McAdams HP. “Crazy-paving” pattern at thin-section CT of the lungs: radiologic-pathologic overview. Radiographics. 2003;23(6):1509–19.CrossRef Rossi SE, Erasmus JJ, Volpacchio M, Franquet T, Castiglioni T, McAdams HP. “Crazy-paving” pattern at thin-section CT of the lungs: radiologic-pathologic overview. Radiographics. 2003;23(6):1509–19.CrossRef
3.
Zurück zum Zitat De Wever W, Meersschaert J, Coolen J, et al. The crazy-paving pattern: a radiological-pathological correlation. Insights Imaging. 2011;2(2):117–32.CrossRef De Wever W, Meersschaert J, Coolen J, et al. The crazy-paving pattern: a radiological-pathological correlation. Insights Imaging. 2011;2(2):117–32.CrossRef
4.
Zurück zum Zitat Gomatou G, Tzilas V, Kourti G, Lagou S, Bouros D, Syrigos K. Crazy paving pattern as a rare radiological manifestation of peripheral T-cell lymphoma (PTCL) with lung involvement: a case report. Respir Med Case Rep. 2018;25:253–6.PubMedPubMedCentral Gomatou G, Tzilas V, Kourti G, Lagou S, Bouros D, Syrigos K. Crazy paving pattern as a rare radiological manifestation of peripheral T-cell lymphoma (PTCL) with lung involvement: a case report. Respir Med Case Rep. 2018;25:253–6.PubMedPubMedCentral
5.
Zurück zum Zitat Sami R, Aeini S, Sadegh R. Crazy-paving pattern due to herpetic pneumonia in a patient with Mycosis fungoides: a case report. Tanaffos. 2017;16(4):309–12.PubMedPubMedCentral Sami R, Aeini S, Sadegh R. Crazy-paving pattern due to herpetic pneumonia in a patient with Mycosis fungoides: a case report. Tanaffos. 2017;16(4):309–12.PubMedPubMedCentral
6.
Zurück zum Zitat Marchiori E, Escuissato DL, Gasparetto TD, Considera DP, Franquet T. “Crazy-paving” patterns on high-resolution CT scans in patients with pulmonary complications after hematopoietic stem cell transplantation. Korean J Radiol. 2009;10(1):21–4.CrossRef Marchiori E, Escuissato DL, Gasparetto TD, Considera DP, Franquet T. “Crazy-paving” patterns on high-resolution CT scans in patients with pulmonary complications after hematopoietic stem cell transplantation. Korean J Radiol. 2009;10(1):21–4.CrossRef
7.
Zurück zum Zitat May RC, Stone NR, Wiesner DL, Bicanic T, Nielsen K. Cryptococcus: from environmental saprophyte to global pathogen. Nat Rev Microbiol. 2016;14(2):106–17.CrossRef May RC, Stone NR, Wiesner DL, Bicanic T, Nielsen K. Cryptococcus: from environmental saprophyte to global pathogen. Nat Rev Microbiol. 2016;14(2):106–17.CrossRef
8.
Zurück zum Zitat Setianingrum F, Rautemaa-Richardson R, Denning DW. Pulmonary cryptococcosis: a review of pathobiology and clinical aspects. Med Mycol. 2019;57(1):133–50.CrossRef Setianingrum F, Rautemaa-Richardson R, Denning DW. Pulmonary cryptococcosis: a review of pathobiology and clinical aspects. Med Mycol. 2019;57(1):133–50.CrossRef
9.
Zurück zum Zitat Zhang Y, Li N, Zhang Y, et al. Clinical analysis of 76 patients pathologically diagnosed with pulmonary cryptococcosis. Eur Respir J. 2012;40(5):1191–200.CrossRef Zhang Y, Li N, Zhang Y, et al. Clinical analysis of 76 patients pathologically diagnosed with pulmonary cryptococcosis. Eur Respir J. 2012;40(5):1191–200.CrossRef
10.
Zurück zum Zitat Orsini J, Blaak C, Tam E, Rajayer S, Morante J. Disseminated cryptococcal infection resulting in Acute Respiratory Distress Syndrome (ARDS) as the initial clinical presentation of AIDS. Intern Med. 2016;55(8):995–8.CrossRef Orsini J, Blaak C, Tam E, Rajayer S, Morante J. Disseminated cryptococcal infection resulting in Acute Respiratory Distress Syndrome (ARDS) as the initial clinical presentation of AIDS. Intern Med. 2016;55(8):995–8.CrossRef
11.
Zurück zum Zitat Liu K, Ding H, Xu B, et al. Clinical analysis of non-AIDS patients pathologically diagnosed with pulmonary cryptococcosis. J Thorac Dis. 2016;8(10):2813–21.CrossRef Liu K, Ding H, Xu B, et al. Clinical analysis of non-AIDS patients pathologically diagnosed with pulmonary cryptococcosis. J Thorac Dis. 2016;8(10):2813–21.CrossRef
12.
Zurück zum Zitat Failly M, Bartoloni L, Letourneau A, et al. Mutations in DNAH5 account for only 15 % of a non-preselected cohort of patients with primary ciliary dyskinesia. J Med Genet. 2009;46(4):281–6.CrossRef Failly M, Bartoloni L, Letourneau A, et al. Mutations in DNAH5 account for only 15 % of a non-preselected cohort of patients with primary ciliary dyskinesia. J Med Genet. 2009;46(4):281–6.CrossRef
13.
Zurück zum Zitat Hornef N, Olbrich H, Horvath J, et al. DNAH5 mutations are a common cause of primary ciliary dyskinesia with outer dynein arm defects. Am J Respir Crit Care Med. 2006;174(2):120–6.CrossRef Hornef N, Olbrich H, Horvath J, et al. DNAH5 mutations are a common cause of primary ciliary dyskinesia with outer dynein arm defects. Am J Respir Crit Care Med. 2006;174(2):120–6.CrossRef
Metadaten
Titel
Crazy‐paving patterns as rare radiological manifestations of pulmonary cryptococcosis: a case report
verfasst von
He Yu
Kaige Wang
Dong Huang
Lu Wen
Ying Zhang
Ye Wang
Yongjiang Tang
Jiajia Dong
Zongan Liang
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
BMC Pulmonary Medicine / Ausgabe 1/2021
Elektronische ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01450-5

Weitere Artikel der Ausgabe 1/2021

BMC Pulmonary Medicine 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.